The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Open accessAbstract
Background A rise in the incidence of some autoimmune disorders has been described. However, contemporary estimates of the overall incidence of autoimmune diseases and trends over time are scarce and inconsistent. We aimed to investigate the incidence and prevalence of 19 of the most common autoimmune diseases in the UK, assess trends over time, and by sex, age, socioeconomic status, season, and region, and we examine rates of co-occurrence among autoimmune diseases.Methods In this UK population-based study, we used linked primary and secondary electronic health records from the Clinical Practice Research Datalink (CPRD), a cohort that is representative of the UK population in terms of age and sex and ethnicity. Eligible participants were men and women (no age restriction) with acceptable records, approved for Hospital Episodes Statistics and Office of National Statistics linkage, and registered with their general practice for at least 12 months during the study period. We calculated age and sex standardised incidence and prevalence of 19 autoimmune disorders from 2000 to 2019 and used negative binomial regression models to investigate temporal trends and variation by age, sex, socioeconomic status, season of onset, and geographical region in England. To characterise co-occurrence of autoimmune diseases, we calculated incidence rate ratios (IRRs), comparing incidence rates of comorbid autoimmune disease among individuals with a first (index) autoimmune disease with incidence rates in the general population, using negative binomial regression models, adjusted for age and sex.Findings Among the 22 009 375 individuals included in the study, 978 872 had a new diagnosis of at least one autoimmune disease between Jan 1, 2000, and June 30, 2019 (mean age 54·0 years [SD 21·4]). 625 879 (63·9%) of these diagnosed individuals were female and 352 993 (36·1%) were male. Over the study period, age and sex standardised incidence rates of any autoimmune diseases increased (IRR 2017-19 vs 2000-02 1·04 [95% CI 1·00-1·09]). The largest increases were seen in coeliac disease (2·19 [2·05-2·35]), Sjogren's syndrome (2·09 [1·84-2·37]), and Graves' disease (2·07 [1·92-2·22]); pernicious anaemia (0·79 [0·72-0·86]) and Hashimoto's thyroiditis (0·81 [0·75-0·86]) significantly decreased in incidence. Together, the 19 autoimmune disorders examined affected 10·2% of the population over the study period (1 912 200 [13·1%] women and 668 264 [7·4%] men). A socioeconomic gradient was evident across several diseases, including pernicious anaemia (most vs least deprived area IRR 1·72 [1·64-1·81]), rheumatoid arthritis (1·52 [1·45-1·59]), Graves' disease (1·36 [1·30-1·43]), and systemic lupus erythematosus (1·35 [1·25-1·46]). Seasonal variations were observed for childhood-onset type 1 diabetes (more commonly diagnosed in winter) and vitiligo (more commonly diagnosed in summer), and regional variations were observed for a range of conditions. Autoimmune disorders were commonly associated with each other, particularly Sjögren's syndrome, systemic lupus erythematosus, and systemic sclerosis. Individuals with childhood-onset type 1 diabetes also had significantly higher rates of Addison's disease (IRR 26·5 [95% CI 17·3-40·7]), coeliac disease (28·4 [25·2-32·0]), and thyroid disease (Hashimoto's thyroiditis 13·3 [11·8-14·9] and Graves' disease 6·7 [5·1-8·5]), and multiple sclerosis had a particularly low rate of co-occurrence with other autoimmune diseases.Interpretation Autoimmune diseases affect approximately one in ten individuals, and their burden continues to increase over time at varying rates across individual diseases. The socioeconomic, seasonal, and regional disparities observed among several autoimmune disorders in our study suggest environmental factors in disease pathogenesis. The inter-relations between autoimmune diseases are commensurate with shared pathogenetic mechanisms or predisposing factors, particularly among connective tissue diseases and among endocrine diseases.Funding Research Foundation Flanders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The incidence of Hashimoto's thyroiditis has been steadily increasing, 26 although the cause is incompletely understood.”
From Hypothyroidism (2024) · cites this paper as [26]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the individual level, hypothyroidism is more common in patients with other autoimmune diseases than in the general population, including rheumatoid arthritis, type 1 diabetes, Addison's disease, and coeliac disease, 26”
From Hypothyroidism (2024) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benchimol, E. I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I., Sørensen, H. T., von Elm, E., Langan, S. M., & RECORD Working Committee (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001885 · Cited by 5,749
Rudwaleit, M., van der Heijde, D. M. F. M., Landewé, R., Listing, J., Akkoç, N., Brandt, J., Braun, J., Chou, C., Collantes‐Estévez, E., Dougados, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108233 · Cited by 3,696
Kirkwood, B. R., & Sterne, J. A. C. (2014) · Bristol Research (University of Bristol) · Cited by 2,820
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
Wolf, A., Dedman, D., Campbell, J., Booth, H., Lunn, D., Chapman, J., & Myles, P. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz034 · Cited by 861
Cooper, G. S., Bynum, M. L. K., & Somers, E. C. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.008 · Cited by 786
Variation and trends in incidence of childhood diabetes in Europe
(2000) · The Lancet · doi:10.1016/s0140-6736(99)07125-1 · Cited by 755
Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis
Mobasseri, M., Shirmohammadi, M., Amiri, T., Vahed, N., Fard, H. H., & Ghojazadeh, M. (2020) · Health Promotion Perspectives · doi:10.34172/hpp.2020.18 · Cited by 744
Global prevalence of ankylosing spondylitis
Dean, L. E., Jones, G. T., MacDonald, A. G., Downham, C., Sturrock, R. D., & Macfarlane, G. J. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/ket387 · Cited by 728
Cited by
Sorted by citations
Items 201–300 of 884
Khor, Y. H., Moor, C. C., Merkt, W., Buschulte, K., Zheng, B., Müller, V., & Kreuter, M. (2025) · European Respiratory Review · doi:10.1183/16000617.0046-2025 · Cited by 9
Gao, W., Tong, H., Yu, H., Chen, R., Wang, Y., Liang, L., Li, Y., & Ma, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115190 · Cited by 8
Sustained immune youth risks autoimmune disease in the aging host
Weyand, C. M., & Goronzy, J. J. (2025) · Nature Aging · doi:10.1038/s43587-025-00919-w · Cited by 9
The new vision from the National Institute of Allergy and Infectious Diseases (NIAID)
Taubenberger, J. K., Powers, J. H., & Bhattacharya, J. (2026) · Nature Medicine · doi:10.1038/s41591-025-04160-1 · Cited by 9
Sex-oriented perspectives in immunopharmacology
Cignarella, A., Vegeto, E., Bolego, C., Trabace, L., Conti, L., & Ortona, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106956 · Cited by 7
Topical antibiotics limit depigmentation in a mouse model of vitiligo
Touni, A. A., Sohn, R., Cosgrove, C., Shivde, R. S., Dellacecca, E. R., Abdel-Aziz, R. T. A., Cedercreutz, K., Green, S. J., Abdel‐Wahab, H., & Poole, I. C. L. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13164 · Cited by 9
Sun, J., Yao, J., Olén, O., Halfvarsson, J., Bergman, D., Ebrahimi, F., Carlsson, S., Ludvigsson, J., & Ludvigsson, J. F. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101056 · Cited by 8
Hernangomez‐Laderas, A., Cilleros‐Portet, A., Velasco, S. M., Marí, S., Legarda, M., González‐García, B. P., Tutau, C., García‐Santisteban, I., Irastorza, I., Fernández‐Jiménez, N., et al. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00572-1 · Cited by 10
Genetic Approaches to Study Rheumatic Diseases and Its Implications in Clinical Practice
Rowczenio, D. M., & Aksentijevich, I. A. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42841 · Cited by 8
ClinVec: Unified Embeddings of Clinical Codes Enable Knowledge-Grounded AI in MedicinePreprint
Johnson, R., Gottlieb, U., Shaham, G., Eisen, L., Waxman, J. G., Devons-Sberro, S., Ginder, C. R., Hong, P. J., Sayeed, R., Su, X., et al. (2024) · medRxiv · doi:10.1101/2024.12.03.24318322 · Cited by 8
Weisbrod, L., Capriotti, L., Hofmann, M., Spieler, V., Dersch, H., Voedisch, B., Schmidt, P. M., & Knake, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386160 · Cited by 7
Research Progress of Natural Active Substances with Immunosuppressive Activity
Shao, F., Shen, Q., Yang, Z., Yang, W., Lu, Z., Zheng, J., Zhang, L., & Li, H.-Y. (2024) · Molecules · doi:10.3390/molecules29102359 · Cited by 7
Masiak, A., Jassem, E., Dębska-Ślizień, A. M., Bułło‐Piontecka, B., Kowalska, B., & Chmielewski, M. S. (2024) · Rheumatology International · doi:10.1007/s00296-024-05631-3 · Cited by 7
Akmatov, M. K., Kohring, C., Peßler, F., & Holstiege, J. (2025) · Research in Health Services & Regions · doi:10.1007/s43999-025-00061-5 · Cited by 7
Tan, H., Ge, H., Qin, Z.-E., Jiang, Y., Chang, S., & Tang, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-97299-3 · Cited by 9
Familial Risk of Hashimoto's Thyroiditis in a Large Genealogical Database
Bujnis, M. N., DeSalvo, K., Neklason, D. W., Madsen, M. J., & Jorde, L. B. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf251 · Cited by 7
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
Jiang, M., Zhao, J., Yuan, J., Yu, Z., Liu, J., Zhu, Z., Ning, X., & Sun, S. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2538350 · Cited by 8
Toward Sex-Specific Biomaterials Innovation: A Perspective
Koons, G. L. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00342 · Cited by 7
Ferroptosis in Autoimmune Diseases: Research Advances and Therapeutic Strategies
He, Z., Liu, B., Xian, Z., Gong, A., & Jia, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110449 · Cited by 7
Tzang, C.-C., Sheng, H., Kuo, V. F.-H., Luo, C.-A., Lin, T.-A., Lee, Y. N., Huang, E. S., Wu, P.-H., Tzang, B., & Hsu, T.-C. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09124-4 · Cited by 8
The role of fermented foods in healthy longevity: A review of potential anti-aging mechanisms
Mu, H., Yao, Y., Gong, Y., & Yang, T. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101300 · Cited by 8
Chong, C. F., Hasnizan, N. Y. U., & Mokhtar, A. M. A. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110855 · Cited by 7
Cheetham, T. D., & Wood, C. L. (2024) · Clinical Endocrinology · doi:10.1111/cen.15110 · Cited by 10
Luo, J., Zhou, L., Sun, A., Min, Y., Lin, Y., & Han, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35114 · Cited by 9
Liu, Y., Yang, Y., Han, Y., Liang, B.-Y., Xie, Z.-H., Zhang, Y., Chen, X.-X., Sang, S.-J., Li, F. F., Han, K., et al. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103679 · Cited by 7
The molecular underpinnings of female predominance in lupus
Κοσμαρά, Δ., Neofotistou-Themeli, E., Semitekolou, M., & Bertsias, G. K. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.11.002 · Cited by 7
Jo, H.-G., Seo, J., Baek, E., & Lee, D. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107616 · Cited by 7
Nix, C., & Fillet, M. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117823 · Cited by 9
Chen, A., Lax, S. J., Grainge, M. J., Lanyon, P., & Pearce, F. (2024) · Rheumatology Advances in Practice · doi:10.1093/rap/rkae086 · Cited by 6
Kerns, S., Owen, K. A., Daamen, A. R., Kain, J., Grammer, A. C., & Lipsky, P. E. (2024) · iScience · doi:10.1016/j.isci.2024.110715 · Cited by 7
Chmiel, J., Stasiak, M., Skrzypkowska, M. W., Samson, L., Łuczkiewicz, P., & Trzonkowski, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36512 · Cited by 6
Tan, Z., Qin, G., Jia, J., Mao, Z., Du, L., Song, R., Xue, H., & Jia, Z. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119004 · Cited by 6
Batko, B. P., Szeląg, M., Krajewska–Włodarczyk, M., Żuber, Z. M., Orleański, M., Podwójcic, K., Sowiński, J., Świderek, M., Maluchnik, M., Batko, K., et al. (2024) · Lara D. Veeken · doi:10.1093/rheumatology/keae670 · Cited by 6
LILRB4 as a novel immunotherapeutic target for multiple diseases
Wang, X., Li, L., Liu, D., Jin, Y., Zhao, X., Li, S., Hou, R., Guan, Z., Ma, W., Zheng, J., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116762 · Cited by 6
Polyautoimmunity Reflecting Immune Dysregulation in Common Variable Immunodeficiency
Danieli, M. G., Murdaca, G., Mezzanotte, C., Claudi, I., Buti, E., Martini, M., Bilò, M. B., Gangemi, S., & Moroncini, G. (2025) · Biomedicines · doi:10.3390/biomedicines13030552 · Cited by 6
Updating on the Dual Role of Salivary Gland Epithelial Cell (SGEC) in Sjögren’s Disease
Zhu, W. T., Lu, Y., Zhu, Y., Huang, X., & Wang, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s509220 · Cited by 6
The burden of rheumatoid arthritis in China from 1990 to 2019 and projections to 2030
Zhou, Y., Luo, X., Li, P., Liu, X., Li, J., Su, L., Gu, X., & Ma, J. (2025) · Public Health · doi:10.1016/j.puhe.2025.02.033 · Cited by 6
Kucharska-Lusina, A., Skrzypek, M., Tokarczyk, A., Dragan, G., & Majsterek, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062489 · Cited by 6
Heppell, C., Subramanian, A., Adderley, N. J., Nirantharakumar, K., Denniston, A. K., Pavesio, C. E., & Braithwaite, T. (2025) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2025.2491567 · Cited by 6
Lin, L., Shan, Y., Lei, F., Zhang, J., Zhang, L., Zhang, X., Yao, W., She, Z., & Li, H. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039451 · Cited by 7
Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century
Nasonov, E. L. (2025) · Terapevticheskii arkhiv · doi:10.26442/00403660.2025.05.203213 · Cited by 6
Jacobs, F., Gaudio, M., Andreottola, C., Borroni, R. G., Benvenuti, C., Saltalamacchia, G., Gerosa, R., Canzian, J., Tiberio, P., Torrisi, R., et al. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf123 · Cited by 6
Saksager, A. B., Hede, F. D., & Barra, C. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103443 · Cited by 6
Thymic B cells in aging and autoimmune disease
Wedemeyer, S. A., & Griffith, A. V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595805 · Cited by 6
Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy
Michels, A. W., Gottlieb, P. A., Nelson, B., & Dayan, C. M. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70091 · Cited by 7
Allogeneic CAR-T cell therapy in autoimmune diseases
Ma, Y., Qin, J., Liu, M., & Du, B. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2572963 · Cited by 7
Gut microbiota: origin or panacea for all ills? Gut microbiota and systemic diseases
Colica, C., Vecchio, I., Aiello, E., Abenavoli, L., Scarlata, G. G. M., & Aiello, V. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108299 · Cited by 6
Bilezikian, J. P., di Filippo, L., Bianchi, A., Bikle, D. D., Binkley, N., Bouillon, R., Fassio, A., Frara, S., Jones, G., Latella, G., et al. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10026-9 · Cited by 6
Chauhan, P., Benninghoff, A. D., Favor, O. K., Wagner, J. G., Lewandowski, R. P., Rajasinghe, L. D., Li, Q., Harkema, J. R., & Pestka, J. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1275265 · Cited by 6
Lan, Y., Lin, X., Yu, J., Li, W., Sun, L., & Huang, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1345672 · Cited by 6
Lickliter, J., Yang, X., Guo, J., Pan, W.-B., & Wei, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380975 · Cited by 7
Early Appearance of Thyroid Autoimmunity in Children Followed From Birth for Type 1 Diabetes Risk
Jonsdottir, B., Clasen, J. L., Vehik, K., Lernmark, Å., Lundgren, M., Bonifacio, E. E., Schatz, D., Ziegler, A., Hagopian, W., Rewers, M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae478 · Cited by 9
Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis
Zo, S., Moon, J., Min, K. H., & Lee, H. J. (2024) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2024.0015 · Cited by 6
Bao, Y., Gu, L., Chen, J., Wang, H., Wang, Z., Wang, H., Wang, S., & Wang, L. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100259 · Cited by 6
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States
Wilson, E., Meeks, H., Barney, B. J., Waltz, M., Canenguez, K. M., Casper, T. C., ROSE, J. W., Rodriguez, M., Tillema, J., Chitnis, T., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209991 · Cited by 7
Rahman, M. F., Kurlovs, A. H., Vodnala, M., Meibalan, E., Means, T. K., Nouri, N., de Rinaldis, E., & Savova, V. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1466368 · Cited by 8
Yang, J., Yang, H., Wang, F., Dai, Y., Deng, Y., Shi, K., Zhu, Z., Liu, X., Ma, X., & Gao, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156332 · Cited by 6
Li, M., Wu, C., Yin, P., Qian, J., Zhao, J., Wang, Q., Xu, D., Su, J., Leng, X., Zheng, W., et al. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.12.021 · Cited by 6
The climate emergency for rheumatologists: where do we stand?
Mruthyunjaya, P., Sondur, S., Ahmed, S., & Grainger, R. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07284-w · Cited by 7
Yao, J., Sun, J., Ebrahimi, F., Bergman, D., Green, P. H. R., Hagström, H., Lebwohl, B., Leffler, D. A., & Ludvigsson, J. F. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101201 · Cited by 6
Influence of Sex in the Development of Liver Diseases
Zhang, J., Zhang, N., Lyu, Y., & Zhang, X. (2025) · Seminars in Liver Disease · doi:10.1055/a-2516-0261 · Cited by 7
Hallab, A., & Initiative, A. D. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-86703-7 · Cited by 6
Nikitina, V. A., Laurini, G. S., Montanaro, N., & Motola, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051644 · Cited by 6
Mandal, M., Mamun, M. A. A., Rakib, A., Kumar, S., Park, F., Hwang, D., Li, W., Miller, D. D., & Singh, U. P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117939 · Cited by 6
Pan, H., Yin, Y., Li, X., Wang, M., Wen, C., Dai, Q., & Huang, L. (2025) · BMC Public Health · doi:10.1186/s12889-025-22093-9 · Cited by 6
Cell therapies for immune-mediated disorders
Krata, N., Foroncewicz, B., Mucha, K., & Zagożdżon, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1550527 · Cited by 6
Rheumatic diseases on the rise
Onuora, S. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00990-w · Cited by 6
The Ethnopharmacology, Phytochemistry and Bioactivities of the Corymbia Genus (Myrtaceae)
Perry, M. J., & Wangchuk, P. (2023) · Plants · doi:10.3390/plants12213686 · Cited by 6
Flores-Chávez, A., Brito‐Zerón, P., Ng, W., Szántó, A., Rasmussen, A., Priori, R., Baldini, C., Armağan, B., Özkiziltaş, B., Praprotnik, S., et al. (2023) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/pmbay6 · Cited by 6
Into the wild: uncertain frontiers and sustainable human–nature interactions
Patterson, J. J. (2024) · Frontiers in Sociology · doi:10.3389/fsoc.2024.1325963 · Cited by 8
Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study
Muntyanu, A., Aw, K., Kaouache, M., Rahme, E., Osman, M., Baron, M., Ghazal, S., & Netchiporouk, E. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100790 · Cited by 6
Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease
Lee, A. Y. S., & Reed, J. H. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12766 · Cited by 6
Akutsu, Y., Ota, M., Itamiya, T., Mori, M., Morio, T., Yamamoto, K., Okamura, T., & Fujio, K. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103355 · Cited by 5
Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review
Hyldahl, E., Schliephake, H., & Jensen, S. S. (2025) · Clinical Oral Implants Research · doi:10.1111/clr.14440 · Cited by 5
Wang, F., Liu, A., Yang, Z., Vartiainen, P., Jukarainen, S., Koskela, S., Oram, R. A., Allen, L. A., Ritari, J., Partanen, J., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100854 · Cited by 5
The role of γδ T cells and CAR-γδ T cell therapy in autoimmune diseases
Wang, T., Wang, H., Lv, R., Wen, C., Wang, M., & Huang, L. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103883 · Cited by 5
Nanobodies targeting cytokines for the amelioration of autoimmune diseases
Vijayandran, K., Abdo, A. I. K., Wong, M. T. J., Balakrishnan, V., Nordin, F., Zaman, W. S. W. K., Lim, C. S. Y., & Tye, G. J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115368 · Cited by 5
Aslan, D., Bourabia, S., Kowall, B., Straukiene, A., Jendretzky, K. F., Konen, F. F., Skripuletz, T., Sıva, A., Yetkin, M. F., Hagenacker, T., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13351-2 · Cited by 6
Pérez‐Sánchez, C., Perez-Campoamor, A., García-Delgado, G. D., Vellón-García, B., Llamas-Urbano, A., Romero-Zurita, L., Ortiz-Buitrago, P., Merlo, C. A., Cerdó, T., Corrales, S., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111325 · Cited by 5
Cross-talk between aging resilience pathways and autoimmunity onset
Mittal, R., Saavedra, D., Mittal, M., & Hirani, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1712575 · Cited by 5
Sinomenine treats Rheumatoid Arthritis by regulating IL-6 Gene Promoter Methylation
Luo, J.-F., Yü, Y., Yao, Y.-D., Zhang, C., Liu, J., Lio, C.-K., Qian, H.-B., & Zhou, H. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157793 · Cited by 5
Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis
Zhao, K., Pershad, Y., Heimlich, J. B., Ormseth, M. J., Stein, C. M., Sharber, B., Vlasschaert, C., Bick, A. G., & Corty, R. W. (2026) · Arthritis & Rheumatology · doi:10.1002/art.70133 · Cited by 9
Immune responses in aging adults
Weyand, C. M., & Goronzy, J. J. (2026) · Journal of Clinical Investigation · doi:10.1172/jci206227 · Cited by 5
Decreasing incidence of celiac disease in Southern Sweden
Lexner, J., Clarkson, S., & Sjöberg, K. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2378045 · Cited by 5
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases
Liu, L., Li, M., Zhang, C., Zhong, Y., Liao, B., Feng, J., & Deng, L. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103733 · Cited by 5
Sun, H., Miao, J., Zhang, K., Zhang, P., Shen, H., Wang, J., Zhang, B., Jia, J., Zheng, Z., & Zhu, P. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70242 · Cited by 5
Elomaa, K., Spick, M. P., Gan, E. H., Pearce, S. H. S., & Geifman, N. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0393 · Cited by 5
Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey
Grixti, L., Fisher, H., Priestley, J., McMullan, C., Woollven, A., Perros, P., Mitchell, A. L., Gan, E. H., & Pearce, S. H. S. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0044 · Cited by 5
Badri, H., Rajai, A., Ward, K., Edmondson, R. J., & Reid, F. M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03916-8 · Cited by 5
Luo, R., Wang, J., & Liu, Y. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07482-6 · Cited by 5
Lupus enteritis as systemic lupus erythematosus main manifestation: Two case reports
Chaparro, C. A., Bernal‐Macías, S., & Múñoz, Ó. (2024) · SAGE Open Medical Case Reports · doi:10.1177/2050313x241247433 · Cited by 5
Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease
Soffritti, I., D’Accolti, M., Bini, F., Mazziga, E., Luca, D. D., Maccari, C., Arcangeletti, M. C., & Caselli, E. (2024) · Biomedicines · doi:10.3390/biomedicines12061360 · Cited by 5
Liu, Q., Jiang, Y., Frisell, T., Stridh, P., Shchetynsky, K., Alfredsson, L. S., Kockum, I. S., Manouchehrinia, A., & Jiang, X. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103294 · Cited by 6
Yamamoto, Y., Shirai, Y., Edahiro, R., Kumanogoh, A., & Okada, Y. (2024) · Immunological Medicine · doi:10.1080/25785826.2024.2394258 · Cited by 5
Implant Treatment in Patients With Autoimmune Diseases: A Systematic Review and Analysis of Studies
Sarafidou, K., Lekatsa, M., Michou, A., Bakopoulou, A., Poulopoulos, A. K., & Andreadis, D. (2024) · Cureus · doi:10.7759/cureus.67617 · Cited by 5
Mandal, M., Rakib, A., Mamun, M. A. A., Kumar, S., Park, F., Hwang, D., Li, W., Miller, D. D., & Singh, U. P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117379 · Cited by 5
Zhang, Y., Wu, Y., Guan, Y., Lu, Y., Zhu, W., Ping, F., & Wang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38421 · Cited by 5
Schistosoma antigens: A future clinical magic bullet for autoimmune diseases?
Chaponda, M., & Lam, H. Y. P. (2024) · Parasite · doi:10.1051/parasite/2024067 · Cited by 6
Spexin as a potential biomarker for autoimmune inflammation in Graves’ disease
Yortanlı, B. Ç., Can, Ü., Yortanlı, M., Kollu, K., Çelikdelen, S. Ö., Catak, G. T., Aksu, O., & Kızılarslanoğlu, M. C. (2025) · Journal of Investigative Medicine · doi:10.1177/10815589251335050 · Cited by 5
Fominykh, V., Shadrin, A. A., Jaholkowski, P. P., Fuhrer, J., Parker, N., Wiström, E. D., Frei, O., Smeland, O. B., Sanner, H., Djurovic, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543781 · Cited by 5
Metadata
- Authors
- Conrad, N., Misra, S., Verbakel, J. Y., Verbeke, G., Molenberghs, G., Taylor, P. N., Mason, J., Sattar, N., McMurray, J. J. V., McInnes, I. B., Khunti, K., & Cambridge, G.
- Affiliations
- University of Oxford (GB)
- Imperial College London (GB)
- Hasselt University (BE)
- Cardiff University (GB)
- University of Glasgow (GB)
- University of Leicester (GB)
- University College London (GB)
- Corresponding author
- Conrad, Nathalie
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 401
- Issue
- 10391
- Pages
- 1878-1890
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4372214968
- Cited by
- 879
- References
- 40
- Citations by year
- 2026: 245 · 2025: 323 · 2024: 258 · 2023: 53
- FWCI
- 185.51
- Type
- journal article
- Language
- en
- Open access
- green
- orca.cardiff.ac.uk
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lirias (submittedVersion, other-oa)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by-nc-nd)
- Funders
- Research Foundation Flanders
- Center for Participatory Research and Development
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- autoimmune disease, incidence, prevalence, temporal trends, comorbidities, socioeconomic status, sex differences, age differences, seasonal variation, regional variation, celiac disease, Sjögren's syndrome, multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, vitiligo, psoriatic arthritis
- MeSH terms
- Anemia, Pernicious, Autoimmune Diseases, Celiac Disease, Child, Diabetes Mellitus, Type 1, England, Female, Graves Disease, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Sjogren's Syndrome, Social Class, Thyroiditis, Cohort Studies, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
